Skip to main content

Home
Specialties
Resources
CME

Search Videos and More

search

Channel Categories

Breast Cancer (21)
Cancer Screening and Survivorship (6)
Cell Therapy (27)
Clinical Trials (22)
COVID-19 (7)
Gastrointestinal Cancer (13)
Genitourinary Cancer (12)
Gynecologic Oncology (12)
Head and Neck Cancer (13)
Hematologic Oncology (36)
Immunotherapy (33)
Neuro-Oncology (8)
Pediatric Hematology/Oncology (9)
Primary Care (10)
Radiation Oncology (11)
Skin Cancer (10)
Thoracic Cancer (16)
Young Adult Malignancies (2)

Types

News (145)

Showing 97 - 108 of 145 results

Previous| 1... 8 | 9 | 10 ...13 |Next

Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma

Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma

From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma

From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma

Roswell Park Expert to Present on Effectiveness of New Combination for Acute Myeloid Leukemia

Roswell Park Expert to Present on Effectiveness of New Combination for Acute Myeloid Leukemia

Roswell Park Researchers Identify Molecular ‘Glue’ That Sticks to and Degrades a Cancer-Causing Protein

Roswell Park Researchers Identify Molecular ‘Glue’ That Sticks to and Degrades a Cancer-Causing Protein

Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy

Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy

Roswell Park Team Shows Dendritic-Cell Vaccines Can Be Paired With Standard Therapy for Breast Cancer

Roswell Park Team Shows Dendritic-Cell Vaccines Can Be Paired With Standard Therapy for Breast Cancer

Roswell Park Experts Share Insights on Diagnosis and Treatment of Head/Neck Cancers at AHNS 2021

Roswell Park Experts Share Insights on Diagnosis and Treatment of Head/Neck Cancers at AHNS 2021

Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells

Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells

Unraveling Tumor-immune Heterogeneity in Advanced Ovarian Cancer

Unraveling Tumor-immune Heterogeneity in Advanced Ovarian Cancer

Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors

Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors

Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma

Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

Showing 97 - 108 of 145 results

Previous| 1... 8 | 9 | 10 ...13 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer